Pure Global AI
NCT06105294Terminated

Time-Restricted Eating and Bipolar Disorder

Time-Restricted Eating as an Adjunctive Intervention for Bipolar Disorder: Acceptability and Feasibility
University of California, BerkeleyClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Bipolar Disorder
Drug/Device/Intervention
time-restricted eating
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of California, Berkeley
Location
Berkeley, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2023
End date
Jul 31, 2023
Enrollment
1 participants
Primary outcome

Acceptability as assessed using self-ratings on items designed for this study,Feasibility as assessed by percent of clients who complete the assessments and intervention

Summary

This is a pilot trial to examine the acceptability and feasibility of time-restricted eating
 as an adjunct to medication treatment for bipolar disorder.

ICD-10 classifications
Bipolar affective disorderBipolar affective disorder, unspecifiedOther bipolar affective disordersBipolar affective disorder, currently in remissionBipolar affective disorder, current episode mixed
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06105294
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06105294 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, Berkeley and is currently Terminated. The study focuses on Bipolar Disorder. Target enrollment is 1 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.